Yunus Gurbuz
Yunus Gurbuz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bahar Ormen
Department of Infectious Diseases, Katip Çelebi University Atatürk Training and Research Hospital, İzmir, Türkiye
1 shared publication - Bilgehan Aygen
Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey
1 shared publication - Emine Türkoğlu
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Tokat Gaziosmanpaşa University, 60030 Tokat, Türkiye
1 shared publication - Güle Çınar
Department of Infectious Diseases and Clinical Microbiology, Ankara University School of Medicine, Ankara, Türkiye
1 shared publication - Neşe Demirtürk
Afyonkarahisar Sağlık Bilimleri Üniversitesi
1 shared publication - Pınar Korkmaz
Kutahya Hlth Sci Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Kutahya, Turkiye
1 shared publication
Latest Publications
- Open Access
- 9 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (Supplement) , 43-75
Management of Chronic Hepatitis C Virus Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update
Direct-acting antiviral (DAA) drugs have increased the effectiveness of treatment in hepatitis C patients. With the developments in the world and DAA drugs coming into use in our country, the consensus report on the management of hepatitis C virus (HCV) infection has needed to be updated. It was first published in 2014 and updated in 2017 by the Viral Hepatitis Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases. Here, the Study Group has reviewed every aspect of chronic hepatitis C and revised the consensus report with the updated information. At the end of each topic, the agreed recommendations are summarized, considering the drugs reimbursed in our country.
- 9 December 2023
- Published by Doc Design and Informatics Co. Ltd. in Klimik Dergisi/Klimik Journal
- Vol. 36 (Supplement) , 43-75
Open AccessManagement of Chronic Hepatitis C Virus Infection: A Consensus Report of the Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases-2023 Update
Direct-acting antiviral (DAA) drugs have increased the effectiveness of treatment in hepatitis C patients. With the developments in the world and DAA drugs coming into use in our country, the consensus report on the management of hepatitis C virus (HCV) infection has needed to be updated. It was first published in 2014 and updated in 2017 by the Viral Hepatitis Study Group of the Turkish Society of Clinical Microbiology and Infectious Diseases. Here, the Study Group has reviewed every aspect of chronic hepatitis C and revised the consensus report with the updated information. At the end of each topic, the agreed recommendations are summarized, considering the drugs reimbursed in our country.